Schond L. Greenway's Net Worth
$6.07 Million
Who is Schond L. Greenway?
Schond L. Greenway has an estimated net worth of $6.07 Million. This is based on reported shares across multiple companies, which include Mind Medicine (MindMed) Inc., and Avalo Therapeutics, Inc..
SEC CIK
Schond L. Greenway's CIK is 0001848205
Past Insider Trading and Trends
2022 was Schond L. Greenway's most active year for acquiring shares with 4 total transactions. Schond L. Greenway's most active month to acquire stocks was the month of April. 2023 was Schond L. Greenway's most active year for disposing of shares, totalling 5 transactions. Schond L. Greenway's most active month to dispose stocks was the month of May. 2021 saw Schond L. Greenway paying a total of $5,250.03 for 502,883 shares, this is the most they've acquired in one year. In 2023 Schond L. Greenway cashed out on 37,397 shares for a total of $133,803.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mind Medicine (MindMed) Inc. (MNMD) Snapshot price: $3.9708
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.57% | -5.56K |
$9.78 | -$54,376.80 | 211.06K |
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| -2.54% | -5.65K |
$3.63 | -$20,516.76 | 216.62K |
Dec 26
| |||
Form 4
| -2.53% | -5.76K |
$3.58 | -$20,608.88 | 222.27K |
Sep 25
| |||
Form 4
| -8.06% | -20.00K |
$3.80 | -$76,000.00 | 228.03K |
Aug 25
| |||
Form 4
| -4.48% | -11.63K |
$3.20 | -$37,194.47 | 248.03K |
Jun 27
| |||
Form 4/A
| +206.69% | 175K |
—
|
—
| 259.67K |
Mar 14
| |||
Form 4
| +13.78% | 175K |
—
|
—
| 1.45M |
Mar 14
| |||
Form 4/A
|
∞
| 1.27M |
—
|
—
| 1.27M |
May 23
| |||
Form 4
|
∞
| 1.27M |
—
|
—
| 1.27M |
May 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avalo Therapeutics, Inc. (AVTX) Snapshot price: $4.34
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +135.05% | 2.23K |
$1.57 | $3,502.67 | 3.88K |
Dec 10
| |||
Form 4
| +65.20% | 652 |
$2.68 | $1,747.36 | 1.65K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||